Template:DrugProjectFormSinglePageEUA: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 87: Line 87:
{{#if: {{{fdaLIADAdult|}}} |
{{#if: {{{fdaLIADAdult|}}} |
{{{fdaLIADAdult|}}} |
{{{fdaLIADAdult|}}} |
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Adult)'' in the drug label.
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Adult)''.
}}
}}


Line 105: Line 105:
{{#if: {{{fdaLIADPed|}}} |
{{#if: {{{fdaLIADPed|}}} |
{{{fdaLIADPed|}}} |
{{{fdaLIADPed|}}} |
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Pediatric)'' in the drug label.
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Pediatric)''.
}}
}}


Line 121: Line 121:
{{#if: {{{contraindications|}}} |
{{#if: {{{contraindications|}}} |
{{{contraindications|}}} |
{{{contraindications|}}} |
There is limited information regarding {{PAGENAME}} ''Contraindications'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Contraindications''.
}}
}}


Line 130: Line 130:
{{#if: {{{warnings|}}}|
{{#if: {{{warnings|}}}|
{{{warnings|}}} |
{{{warnings|}}} |
There is limited information regarding {{PAGENAME}} ''Warnings' in the drug label.
There is limited information regarding {{PAGENAME}} ''Warnings'.
}}
}}


Line 138: Line 138:
{{#if: {{{clinicalTrials|}}} |
{{#if: {{{clinicalTrials|}}} |
{{{clinicalTrials|}}} |
{{{clinicalTrials|}}} |
There is limited information regarding {{PAGENAME}} ''Clinical Trials Experience'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Clinical Trials Experience''.
}}
}}


Line 144: Line 144:
{{#if: {{{postmarketing|}}} |
{{#if: {{{postmarketing|}}} |
{{{postmarketing|}}} |
{{{postmarketing|}}} |
There is limited information regarding {{PAGENAME}} ''Postmarketing Experience'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Postmarketing Experience''.
}}
}}


Line 150: Line 150:
{{#if: {{{drugInteractions|}}} |
{{#if: {{{drugInteractions|}}} |
{{{drugInteractions|}}} |
{{{drugInteractions|}}} |
There is limited information regarding {{PAGENAME}} ''Drug Interactions'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Drug Interactions''.
}}
}}


Line 236: Line 236:
{{#if: {{{administration|}}} |
{{#if: {{{administration|}}} |
{{{administration|}}} |
{{{administration|}}} |
There is limited information regarding {{PAGENAME}} ''Administration'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Administration''.
}}
}}


Line 242: Line 242:
{{#if: {{{monitoring|}}} |
{{#if: {{{monitoring|}}} |
{{{monitoring|}}} |
{{{monitoring|}}} |
There is limited information regarding {{PAGENAME}} ''Monitoring'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Monitoring''.
}}
}}


Line 260: Line 260:
{{#if: {{{drugBox|}}} |
{{#if: {{{drugBox|}}} |
{{{drugBox|}}} |
{{{drugBox|}}} |
There is limited information regarding {{PAGENAME}} ''Pharmacology'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Pharmacology''.
}}
}}


Line 266: Line 266:
{{#if: {{{mechAction|}}} |
{{#if: {{{mechAction|}}} |
{{{mechAction|}}} |
{{{mechAction|}}} |
There is limited information regarding {{PAGENAME}} ''Mechanism of Action'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Mechanism of Action''.
}}
}}


Line 272: Line 272:
{{#if: {{{structure|}}} |
{{#if: {{{structure|}}} |
{{{structure|}}} |
{{{structure|}}} |
There is limited information regarding {{PAGENAME}} ''Structure'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Structure''.
}}
}}


Line 278: Line 278:
{{#if: {{{PD|}}} |
{{#if: {{{PD|}}} |
{{{PD|}}} |
{{{PD|}}} |
There is limited information regarding {{PAGENAME}} ''Pharmacodynamics'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Pharmacodynamics''.
}}
}}


Line 284: Line 284:
{{#if: {{{PK|}}} |
{{#if: {{{PK|}}} |
{{{PK|}}} |
{{{PK|}}} |
There is limited information regarding {{PAGENAME}} ''Pharmacokinetics'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Pharmacokinetics''.
}}
}}


Line 290: Line 290:
{{#if: {{{nonClinToxic|}}} |
{{#if: {{{nonClinToxic|}}} |
{{{nonClinToxic|}}} |
{{{nonClinToxic|}}} |
There is limited information regarding {{PAGENAME}} ''Nonclinical Toxicology'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Nonclinical Toxicology''.
}}
}}


Line 296: Line 296:
{{#if: {{{clinicalStudies|}}} |
{{#if: {{{clinicalStudies|}}} |
{{{clinicalStudies|}}} |
{{{clinicalStudies|}}} |
There is limited information regarding {{PAGENAME}} ''Clinical Studies'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Clinical Studies''.
}}
}}


Line 302: Line 302:
{{#if: {{{howSupplied|}}} |
{{#if: {{{howSupplied|}}} |
{{{howSupplied|}}} |
{{{howSupplied|}}} |
There is limited information regarding {{PAGENAME}} ''How Supplied'' in the drug label.
There is limited information regarding {{PAGENAME}} ''How Supplied''.
}}
}}


Line 308: Line 308:
{{#if: {{{storage|}}} |
{{#if: {{{storage|}}} |
{{{storage|}}} |
{{{storage|}}} |
There is limited information regarding {{PAGENAME}} ''Storage'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Storage''.
}}
}}


Line 331: Line 331:
|sort=Pill Name
|sort=Pill Name
}}
}}
<!---
===Package and Label Display Panel===
===Package and Label Display Panel===
{{{packLabel|}}}
{{{packLabel|}}}
Line 340: Line 342:
|sort=Label Page
|sort=Label Page
}}
}}
--->
==Patient Counseling Information==
==Patient Counseling Information==
{{#if: {{{fdaPatientInfo|}}} |
{{#if: {{{fdaPatientInfo|}}} |
{{{fdaPatientInfo|}}} |
{{{fdaPatientInfo|}}} |
There is limited information regarding {{PAGENAME}} ''Patient Counseling Information'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Patient Counseling Information''.
}}
}}


Line 355: Line 359:
{{#if: {{{brandNames|}}} |
{{#if: {{{brandNames|}}} |
{{{brandNames|}}} |
{{{brandNames|}}} |
There is limited information regarding {{PAGENAME}} ''Brand Names'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Brand Names''.
}}
}}


Line 361: Line 365:
{{#if: {{{lookAlike|}}} |
{{#if: {{{lookAlike|}}} |
{{{lookAlike|}}} |
{{{lookAlike|}}} |
There is limited information regarding {{PAGENAME}} ''Look-Alike Drug Names'' in the drug label.
There is limited information regarding {{PAGENAME}} ''Look-Alike Drug Names''.
}}
}}



Revision as of 18:35, 3 July 2020

This is the "Drug Project Form" template. It should be called in the following format:

{{DrugProjectForm
|authorTag=
|genericName=
|drugClass=
|indication=
|indicationType=
|commonAdverseReactions=
|hasBlackBoxWarning=
|blackBoxWarningTitle=
|blackBoxWarningBody=
|fdaLIADAdult=
|offLabelAdultGuideSupport=
|offLabelAdultNoGuideSupport=
|fdaLIADPed=
|offLabelPedGuideSupport=
|offLabelPedNoGuideSupport=
|contraindications=
|warnings=
|adverseReactions=
|clinicalTrials=
|postmarketing=
|drugInteractions=
|FDAPregCat=
|useInPregnancyFDA=
|AUSPregCat=
|useInPregnancyAUS=
|useInLaborDelivery=
|useInNursing=
|useInPed=
|useInGeri=
|useInGender=
|useInRace=
|useInRenalImpair=
|useInHepaticImpair=
|useInReproPotential=
|useInImmunocomp=
|othersTitle=
|useInOthers=
|administration=
|monitoring=
|IVCompat=
|overdose=
|drugBox=
|mechAction=
|structure=
|PD=
|PK=
|nonClinToxic=
|clinicalStudies=
|howSupplied=
|NDC=
|storage= 
|manBy=  
|distBy=
|drugImages=
|packLabel=
|fdaPatientInfo=
|nlmPatientInfo=
|alcohol=
|brandNames=
|lookAlike=
|drugShortage=
|price=
}}

Edit the page to see the template text.